Franco Locatelli to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications Franco Locatelli has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
2.637
-
Role of interferon-? in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation. Haematologica. 2019 11; 104(11):2314-2323.
Score: 0.283
-
Unrelated donor vs HLA-haploidentical a/ß T-cell- and B-cell-depleted HSCT in children with acute leukemia. Blood. 2018 12 13; 132(24):2594-2607.
Score: 0.277
-
Hematopoietic Stem Cell Transplantation in Thalassemia. Hematol Oncol Clin North Am. 2018 04; 32(2):317-328.
Score: 0.266
-
How I treat myelodysplastic syndromes of childhood. Blood. 2018 03 29; 131(13):1406-1414.
Score: 0.264
-
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2017 08; 18(8):1126-1136.
Score: 0.253
-
Outcome of children with acute leukemia given HLA-haploidentical HSCT after aß T-cell and B-cell depletion. Blood. 2017 08 03; 130(5):677-685.
Score: 0.252
-
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood. 2005 Jan 01; 105(1):410-9.
Score: 0.104
-
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation. Front Immunol. 2019; 10:1179.
Score: 0.072
-
NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia. Trends Immunol. 2018 07; 39(7):577-590.
Score: 0.067
-
Human ?d T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias. Front Immunol. 2018; 9:984.
Score: 0.067
-
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy. Biol Blood Marrow Transplant. 2018 06; 24(6):1223-1231.
Score: 0.066
-
Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia. Br J Haematol. 2018 03; 180(5):680-693.
Score: 0.066
-
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation. Bone Marrow Transplant. 2018 05; 53(5):521-534.
Score: 0.066
-
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study. J Allergy Clin Immunol. 2018 03; 141(3):1036-1049.e5.
Score: 0.065
-
High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study. Br J Haematol. 2017 12; 179(5):772-780.
Score: 0.065
-
A New Enzyme-Linked Immunosorbent Assay for a Total Anti-T Lymphocyte Globulin Determination: Development, Analytical Validation, and Clinical Applications. Ther Drug Monit. 2017 06; 39(3):282-289.
Score: 0.063
-
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. JCI Insight. 2017 02 09; 2(3):e89798.
Score: 0.062
-
Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood. 2015 Apr 02; 125(14):2311-3.
Score: 0.054
-
Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry. Br J Haematol. 2014 Jun; 165(5):673-81.
Score: 0.050
-
Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency. Pediatr Transplant. 2009 Sep; 13(6):785-9.
Score: 0.035
-
Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):1970-1985.e4.
Score: 0.018
-
The novel HLA-DRB3*02:02:11 allele identified in an Italian individual. HLA. 2018 12; 92(6):423-424.
Score: 0.017
-
Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience. Acta Haematol. 2018; 140(2):105-111.
Score: 0.017
-
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia. Blood Cancer J. 2018 08 22; 8(9):80.
Score: 0.017
-
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nat Commun. 2017 12 19; 8(1):2126.
Score: 0.016
-
Open issues in Mucopolysaccharidosis type I-Hurler. Orphanet J Rare Dis. 2017 06 15; 12(1):112.
Score: 0.016
-
Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups. Pediatr Blood Cancer. 2017 Dec; 64(12).
Score: 0.016
-
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. Clin Immunol. 2010 Aug; 136(2):269-81.
Score: 0.010
-
Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia. Blood. 2008 Feb 01; 111(3):1124-7.
Score: 0.008
-
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. Br J Haematol. 2002 Sep; 118(3):741-7.
Score: 0.006